| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2021 | CRON Cronos Group Inc. | Adler Jason Marc49 | - | Sell | 714,759 | $10.07 | $7,194,549.67 | -8.0% | -14.8% | -66.0% | |
| Mar 17, 2021 | UTHR United Therapeutics Corp | Olian Judy D.60 | Director | Sell | 2,103 | $170.00 | $357,510.00 | -26.6% | +4.3% | +7.8% | |
| Mar 17, 2021 | PRGO Perrigo Co Plc | Parker Geoffrey M.46 | Director | Buy | 2,500 | $41.29 | $103,217.75 | +1,667% | +15.2% | -4.7% | |
| Mar 17, 2021 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 3,520 | $71.42 | $251,405.60 | -11.8% | -15.5% | +3.9% | |
| Mar 16, 2021 | TEVA Teva Pharmaceutical Industries Ltd | Sabag Mark | See "remarks" Below | Sell | 127,244 | $11.22 | $1,427,614.06 | -86.1% | -0.5% | -30.0% | |
| Mar 15, 2021 | ANIP Ani Pharmaceuticals Inc | Walsh Patrick D52 | Director | Buy | 4,000 | $32.89 | $131,555.20 | +11.4% | +4.9% | -12.1% | |
| Mar 15, 2021 | AMRX Amneal Pharmaceuticals, Inc. | Todisco Joseph76 | Executive Vice President | Sell | 36,330 | $6.82 | $247,865.06 | -11.5% | -17.5% | -43.1% | |
| Mar 15, 2021 | PCRX Pacira Biosciences, Inc. | Froimson Mark72 | Director | Sell | 734 | $72.26 | $53,038.84 | -12.3% | -17.2% | -2.6% | |
| Mar 15, 2021 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Director | Sell | 50,075 | $25.30 | $1,266,773.72 | -81.8% | -7.7% | -27.2% | |
| Mar 15, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 4,244 | $19.03 | $80,745.07 | -4.7% | +2.8% | +81.4% | |
| Mar 15, 2021 | BTAI Bioxcel Therapeutics, Inc. | Yocca Frank88 | Chief Scientific Officer | Sell | 15,000 | $48.50 | $727,572.90 | -11.3% | -21.2% | -69.1% | |
| Mar 15, 2021 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita53 | Executive Vice President | Sell | 36,330 | $6.87 | $249,489.01 | -14.6% | -17.5% | -43.1% | |
| Mar 15, 2021 | CRON Cronos Group Inc. | Adler Jason Marc49 | - | Sell | 452,810 | $10.65 | $4,823,649.09 | -4.9% | -16.9% | -70.9% | |
| Mar 15, 2021 | PCRX Pacira Biosciences, Inc. | Wicki Andreas71 | Director | Sell | 69,355 | $73.19 | $5,075,999.08 | -7.1% | -17.2% | -2.6% | |
| Mar 15, 2021 | CRON Cronos Group Inc. | Gorenstein Michael Ryan77 | Executive Chairman | Sell | 604,411 | $10.35 | $6,255,064.91 | -2.3% | -16.9% | -70.9% | |
| Mar 11, 2021 | YCBD Cbdmd, Inc. | Sumichrast Martin A.83 | Chairman &Co-ceo | Sell | 125,000 | $3.98 | $497,681.02 | -4.1% | -24.8% | -80.9% | |
| Mar 11, 2021 | PCRX Pacira Biosciences, Inc. | Wicki Andreas71 | Director | Sell | 172,191 | $71.92 | $12,384,677.50 | -8.9% | -15.9% | -2.0% | |
| Mar 11, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 18,142 | $0.96 | $17,365.57 | - | - | - | |
| Mar 10, 2021 | PRGO Perrigo Co Plc | Janish Ronald Craig61 | EVP, Gbl Ops &Sc &CTO | Sell | 2,662 | $41.23 | $109,766.24 | -18.5% | +13.1% | -7.5% | |
| Mar 10, 2021 | IRWD Ironwood Pharmaceuticals Inc | Denner Alexander J66 | Director, 10% Owner | Buy | 225,000 | $10.38 | $2,335,500.00 | +0.7% | +3.0% | +5.3% | |
| Mar 9, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 59,959 | $209.79 | $12,579,031.59 | - | +8.4% | +29.4% | |
| Mar 9, 2021 | CRON Cronos Group Inc. | Gorenstein Michael Ryan77 | Executive Chairman | Sell | 185,000 | $10.00 | $1,849,297.00 | -2.0% | - | - | |
| Mar 8, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 125,284 | $209.69 | $26,271,092.03 | - | +7.9% | +27.4% | |
| Mar 8, 2021 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | SVP And General Counsel | Sell | 6,769 | $18.97 | $128,378.95 | -3.1% | - | - | |
| Mar 5, 2021 | LNTH Lantheus Holdings, Inc. | Maeusli Heinz Christoph | Director | Buy | 1,000 | $18.60 | $18,600.00 | +6.6% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.